Quality of life at work and fatigue after hospitalization due to COVID‐19

Author:

Mazurkiewicz Iwona12,Chatys‐Bogacka Zaneta12,Slowik Joanna3,Szaleniec Joanna45,Czepiel Jacek67,Slowik Agnieszka12,Drabik Leszek89,Wnuk Marcin12ORCID

Affiliation:

1. Jagiellonian University Medical College Department of Neurology Krakow Poland

2. Department of Neurology University Hospital in Krakow Krakow Poland

3. Department of Periodontology, Preventive Dentistry and Oral Medicine, Institute of Dentistry, Faculty of Medicine Jagiellonian University Medical College Krakow Poland

4. Department of Otorhinolaryngology University Hospital in Krakow Krakow Poland

5. Department of Otorhinolaryngology Jagiellonian University Medical College Krakow Poland

6. Department of Infectious Diseases University Hospital in Krakow Krakow Poland

7. Department of Infectious Diseases Jagiellonian University Medical College Krakow Poland

8. Department of Pharmacology Jagiellonian University Medical College Krakow Poland

9. John Paul II Hospital Krakow Poland

Abstract

AbstractObjectiveTo evaluate course of quality of life (QoL) after hospitalization due to COVID‐19 and to assess whether symptoms of chronic fatigue syndrome (CFS) were its predictors at different time points.MethodsParticipants aged 18 or older retrospectively reported QoL at work with 4‐point Likert scale and presence of eight CFS symptoms before infection, within 0–4, 4–12, and > 12 weeks post‐COVID with online or paper version of validated neuropsychological questionnaire.ResultsTwo hundred and eighty‐three patients (median age 59 [47–67] years, 37.45% women, 95.76% non‐ICU residents) were evaluated after median of 27.1 (24.9–31.6) weeks from first positive swab test for SARS‐CoV‐2. Any decrease in QoL at work was observed in 33.21%, 29.28%, and 25.54% of patients within 4, 4–12, and > 12 weeks after COVID‐19, respectively (p < 0.001). Within 4 weeks after COVID‐19 onset, decrease in QoL at work was predicted by age (OR = 0.93, 95% CI:0.90–0.96, p < 0.001), persistent fatigue unrelated to effort (OR = 4.03, 95% CI:1.21–13.50, p < 0.001), sore throat (OR = 5.33, 95% CI:1.92–14.78, p = 0.001), and prolonged post‐exercise fatigue (OR = 8.12, 95% CI:2.17–30.56, p = 0.002). Predictors of deterioration in QoL at work 4–12 and > 12 weeks post‐infection were age (OR = 0.97, 95% CI:0.94–0.99, p = 0.015 and OR = 0.93, 95% CI:0.90–0.97, p = 0.001, respectively), non‐restorative sleep (OR = 2.75, 95% CI:1.25–6.05, p = 0.012 and OR = 3.62, 95% CI:1.40–9.38, p = 0.008, respectively), and headache (OR = 2.78, 95% CI:1.29–5.99, p = 0.009 and OR = 5.68, 95% CI:2.15–15.02, p < 0.001, respectively). Furthermore, decreased QoL at work was predicted by post‐exercise fatigue (OR = 5.99, 95% CI:2.18–16.20, p < 0.001) and fatigue not caused by effort (OR = 14.40, 95% CI:4.77–43.45, p < 0.001) within 4–12 and > 12 weeks post‐infection, respectively.ConclusionsDifferent CFS symptoms are associated with decreased QoL at work at various time points since COVID‐19 onset.

Funder

Narodowe Centrum Badań i Rozwoju

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference30 articles.

1. Neurological manifestations in SARS‐CoV ‐2 infection: A single‐center cross‐sectional study in Malaysia

2. Most common long COVID physical symptoms in working age adults who experienced mild COVID‐19 infection: a scoping review;Kokolevich ZM;Dent Health,2022

3. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study

4. A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID

5. Long‐term health consequences of COVID‐19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID‐19 severity and associated risk factors;Jain V;J Clin Nurs,2023

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3